Biotech, Pharma Cos. Eye Impact Of DOJ's Foreign Data Rule
Facing deadline pressure, biotechnology and pharmaceutical organizations are moving fast to analyze whether a new U.S. Department of Justice proposal to restrict data-sharing with China and five other countries will disrupt...To view the full article, register now.
Already a subscriber? Click here to view full article